Research ArticleThe State of the Art
Open Access
68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu
Journal of Nuclear Medicine February 2021, 62 (2) 149-155; DOI: https://doi.org/10.2967/jnumed.120.260455
Giuseppe Carlucci
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and
Robin Ippisch
2Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
Roger Slavik
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and
Ashley Mishoe
2Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
Joseph Blecha
2Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
Shaojun Zhu
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha, Shaojun Zhu
Journal of Nuclear Medicine Feb 2021, 62 (2) 149-155; DOI: 10.2967/jnumed.120.260455
Jump to section
Related Articles
Cited By...
- No citing articles found.